Ninkov, Marina
Schmerk, Crystal L.
Moradizadeh, Manoosh
Parvathy, Seema N.
Figueredo, Rene
Burton, Jeremy P.
Silverman, Michael S.
Fernandes, Ricardo
Maleki Vareki, Saman
Haeryfar, S. M. Mansour http://orcid.org/0000-0002-1125-8176
Clinical trials referenced in this document:
Documents that mention this clinical trial
Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma
https://doi.org/10.1007/s00262-022-03329-8
Funding for this research was provided by:
London Regional Cancer Program (Keith Samitt Translational Research Catalyst Grant)
Canadian Cancer Society (Innovation Grant 706396)
Article History
Received: 7 September 2022
Accepted: 9 November 2022
First Online: 18 November 2022
Declarations
:
: The authors declare that they have no conflicts of interest. S.M. Mansour Haeryfar currently serves on the Editorial Board of Cancer Immunology, Immunotherapy.
: Human specimens were collected and used as per study protocols 5545 and 114962 approved by the Western University Research Ethics Board for Health Sciences Research Involving Human Subjects.
: Informed consent was obtained from all patients and healthy blood donors who participated in this study.
Free to read: This content has been made available to all.